tradingkey.logo

Inogen Inc

INGN
6.750USD
+0.040+0.60%
收盤 12/22, 16:00美東報價延遲15分鐘
183.25M總市值
虧損本益比TTM

Inogen Inc

6.750
+0.040+0.60%

關於 Inogen Inc 公司

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.

Inogen Inc簡介

公司代碼INGN
公司名稱Inogen Inc
上市日期Feb 14, 2014
CEOSmith (Kevin R. M)
員工數量766
證券類型Ordinary Share
年結日Feb 14
公司地址859 Ward Drive
城市GOLETA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編93111
電話18055620500
網址https://www.inogen.com/
公司代碼INGN
上市日期Feb 14, 2014
CEOSmith (Kevin R. M)

Inogen Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
55.01K
+125.45%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
55.01K
+125.45%
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
49.15K
+3.15%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
37.25K
+100.00%
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
30.61K
--
Mr. Naga Rameswamy
Mr. Naga Rameswamy
Chief Technology Officer
Chief Technology Officer
--
--
Ms. Jennifer Boyer
Ms. Jennifer Boyer
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
--
--
Mr. Kevin P. Smith
Mr. Kevin P. Smith
Executive Vice President - Business Development, General Counsel, Secretary
Executive Vice President - Business Development, General Counsel, Secretary
--
--
Ms. Elizabeth (Beth) Mora, CPA
Ms. Elizabeth (Beth) Mora, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kevin R. M. Smith
Mr. Kevin R. M. Smith
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
55.01K
+125.45%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
55.01K
+125.45%
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
49.15K
+3.15%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
37.25K
+100.00%
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
30.61K
--
Mr. Naga Rameswamy
Mr. Naga Rameswamy
Chief Technology Officer
Chief Technology Officer
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
U.S. revenue
56.35M
61.07%
Non-U.S. revenue
35.92M
38.93%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.67%
BlackRock Institutional Trust Company, N.A.
5.50%
The Vanguard Group, Inc.
5.27%
Acadian Asset Management LLC
3.93%
Camber Capital Management LP
3.59%
其他
72.04%
持股股東
持股股東
佔比
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.67%
BlackRock Institutional Trust Company, N.A.
5.50%
The Vanguard Group, Inc.
5.27%
Acadian Asset Management LLC
3.93%
Camber Capital Management LP
3.59%
其他
72.04%
股東類型
持股股東
佔比
Investment Advisor
25.98%
Investment Advisor/Hedge Fund
25.85%
Hedge Fund
18.26%
Corporation
9.67%
Individual Investor
2.48%
Research Firm
1.98%
Family Office
0.89%
Pension Fund
0.27%
Bank and Trust
0.20%
其他
14.42%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
308
19.98M
73.65%
-4.59M
2025Q2
330
22.77M
84.68%
-2.73M
2025Q1
372
22.71M
84.47%
-2.93M
2024Q4
375
21.79M
82.19%
-5.25M
2024Q3
367
21.78M
91.28%
-6.90M
2024Q2
360
23.19M
97.91%
-6.59M
2024Q1
364
22.78M
97.44%
-4.92M
2023Q4
369
22.26M
95.31%
-4.56M
2023Q3
386
22.05M
94.85%
-5.76M
2023Q2
403
22.24M
96.20%
-5.90M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
2.63M
9.71%
+2.63M
--
Feb 21, 2025
BlackRock Institutional Trust Company, N.A.
1.52M
5.61%
-63.70K
-4.03%
Jun 30, 2025
The Vanguard Group, Inc.
1.65M
6.12%
+113.18K
+7.35%
Jun 30, 2025
Acadian Asset Management LLC
1.02M
3.76%
-11.08K
-1.08%
Jun 30, 2025
Camber Capital Management LP
975.00K
3.61%
--
--
Jun 30, 2025
Armistice Capital LLC
664.00K
2.46%
+664.00K
--
Jun 30, 2025
Columbia Threadneedle Investments (US)
881.10K
3.26%
+6.57K
+0.75%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
832.19K
3.08%
+75.07K
+9.91%
Jun 30, 2025
Geode Capital Management, L.L.C.
615.28K
2.28%
+44.86K
+7.86%
Jun 30, 2025
Dafna Capital Management, LLC
605.63K
2.24%
+147.56K
+32.21%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Cultivar ETF
0.59%
Invesco NASDAQ Future Gen 200 ETF
0.55%
Federated Hermes MDT Small Cap Core ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.11%
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
查看更多
Cultivar ETF
佔比0.59%
Invesco NASDAQ Future Gen 200 ETF
佔比0.55%
Federated Hermes MDT Small Cap Core ETF
佔比0.25%
JPMorgan Fundamental Data Science Small Core ETF
佔比0.11%
iShares Micro-Cap ETF
佔比0.04%
Avantis US Small Cap Equity ETF
佔比0.02%
Proshares Ultra Russell 2000
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Inogen Inc的前五大股東是誰?

Inogen Inc的前五大股東如下:
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
持有股份:2.63M
佔總股份比例:9.71%。
BlackRock Institutional Trust Company, N.A.
持有股份:1.52M
佔總股份比例:5.61%。
The Vanguard Group, Inc.
持有股份:1.65M
佔總股份比例:6.12%。
Acadian Asset Management LLC
持有股份:1.02M
佔總股份比例:3.76%。
Camber Capital Management LP
持有股份:975.00K
佔總股份比例:3.61%。

Inogen Inc的前三大股東類型是什麼?

Inogen Inc 的前三大股東類型分別是:
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.

有多少機構持有Inogen Inc(INGN)的股份?

截至2025Q3,共有308家機構持有Inogen Inc的股份,合計持有的股份價值約為19.98M,占公司總股份的73.65% 。與2025Q2相比,機構持股有所增加,增幅為-11.03%。

哪個業務部門對Inogen Inc的收入貢獻最大?

在FY2025Q2,--業務部門對Inogen Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI